TargED Biopharmaceuticals has completed the second closing of its Series A2 financing round.
Deal: TargED Biopharmaceuticals has successfully completed the second closing of its Series A2 financing round, raising €40.4 million. This brings the total Series A financing to more than €80 million.
Value: $80 million
Sector: technology
Date: 1 July 2026